Related Experiment Video

Updated: Aug 18, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation

Nicholas Trakul1, Raymond E Menard, George R Schade

  • 1Committee on Cancer Biology, University of Chicago, Chicago, Illinois 60637, USA.

The Journal of Biological Chemistry
|May 12, 2005
PubMed

Insights

Raf kinase inhibitory protein (RKIP) suppresses cancer by inhibiting Raf-1 activation, a key step in the MAPK signaling cascade. RKIP depletion enhances MAPK signaling, impacting growth and development.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Raf kinase inhibitory protein (RKIP) modulates the Raf/MAPK signaling cascade.
  • RKIP is recognized as a suppressor of metastatic cancer.
  • The Raf/MAPK pathway is crucial for cell growth, proliferation, and differentiation.

Purpose of the Study:

  • To elucidate the mechanism by which RKIP inhibits MAPK signaling.
  • To investigate the role of RKIP in regulating Raf-1 activation.
  • To determine the impact of RKIP on MAPK signaling dynamics and cellular responses to growth factors.

Main Methods:

  • Investigated RKIP's effect on Raf-1 activation, including its interaction with p21-activated kinase (PAK) and Src family kinases.
  • Utilized site-directed mutagenesis to probe the importance of Raf-1 phosphorylation sites.
  • Performed RKIP depletion experiments to assess its influence on MAPK signaling and DNA synthesis in response to epidermal growth factor (EGF).

Main Results:

  • RKIP inhibits MAPK signaling by preventing Raf-1 and PAK association and blocking Raf-1 phosphorylation by PAK and Src kinases.
  • Mutating critical Raf-1 phosphorylation sites abolished RKIP's inhibitory effect.
  • RKIP depletion significantly increased the amplitude and sensitivity of MAPK signaling and DNA synthesis to EGF stimulation.
  • RKIP selectively modulates c-Raf-1 but not B-Raf activation.

Conclusions:

  • RKIP's selective inhibition of c-Raf-1 activation limits the dynamic range of MAPK signaling.
  • This modulation by RKIP plays a critical role in regulating cellular responses to growth factors.
  • Understanding RKIP's function offers insights into cancer suppression and developmental processes.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...